Showing results (1411-1420 of 2,010) with videos related to
Sort By:
Pageof 201
Nature Medicine|October 23, 2023
Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitisOlga V Britanova, Kseniia R Lupyr, Dmitry B Staroverov, et al.Arxiv|June 19, 2023
Evaluation of software impact designed for biomedical research: Are we measuring what's meaningful?Awan Afiaz, Andrey A Ivanov, John Chamberlin, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 4, 2019
[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a]A N Boyko, L P Bosenko, V V Vasilovskiy, et al.Frontiers in Public Health|July 17, 2026
A cross-sectional study of seroprevalence in Armenia, 2025: measles, mumps, rubella, and diphtheriaA Y Popova, V S Smirnov, S A Egorova, et al.The Review of Scientific Instruments|March 6, 2014
Development of a negative ion-based neutral beam injector in NovosibirskA A Ivanov, G F Abdrashitov, V V Anashin, et al.Nature|December 10, 2015
Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regenerationCaroline A Lindemans, Marco Calafiore, Anna M Mertelsmann, et al.Medical Microbiology and Immunology|July 2, 2022
SARS-CoV-2 herd immunity of the Kyrgyz population in 2021Anna Y Popova, Omor T Kasymov, Vyacheslav Y Smolenski, et al.Microbiology Spectrum|September 30, 2024
Bacteroides vesicles promote functional alterations in the gut microbiota compositionOlga Yu Shagaleeva, Daria A Kashatnikova, Dmitry A Kardonsky, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 1, 2017
[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study]A N Boyko, N Yu Lashch, S N Sharanova, et al.Physical Review Letters|August 12, 2025
First Search for Axion Dark Matter with a MADMAX PrototypeB Ary Dos Santos Garcia, D Bergermann, A Caldwell, et al.Pageof 201